Skip to main content
Premium Trial:

Request an Annual Quote

GATC Biotech Purchases HiSeq 2000 Instrument

Premium

This article was originally published Jan. 21.

German service provider GATC Biotech said last week that it has purchased an Illumina HiSeq 2000 sequencer for its Constance laboratory.

The company said in a statement that the new platform, which Illumina launched earlier this month (see In Sequence 1/12/2010), will initially be used for human genome sequencing projects from customers in pharmaceutical and medical research. In addition, GATC plans to offer services on the system to industrial and academic researchers interested in sequencing large eukaryotic genomes.

GATC Biotech CEO Peter Pohl said in a statement that the system, which will complement the firm's three existing Illumina Genome Analyzer IIx sequencers, will be "quickly installed and geared up for production."

The company also has several Roche GS FLX and Applied Biosystems 3730xl sequencers installed, and has been testing Complete Genomics' human genome sequencing service.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.